Free Trial
OTCMKTS:ATBPF

Antibe Therapeutics (ATBPF) Stock Price, News & Analysis

Antibe Therapeutics logo
$0.22 0.00 (0.00%)
As of 04/16/2025

About Antibe Therapeutics Stock (OTCMKTS:ATBPF)

Key Stats

Today's Range
$0.22
$0.22
50-Day Range
$0.22
$0.22
52-Week Range
$0.11
$0.89
Volume
N/A
Average Volume
27,352 shs
Market Capitalization
$11.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATBPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATBPF Stock News Headlines

APLIF Appili Therapeutics Inc.
Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
Antibe Announces Appointment of Receiver
Antibe Announces Appointment of Receiver
Antibe Provides Update on CCAA Proceedings
Antibe Announces TSX Delisting Review
See More Headlines

ATBPF Stock Analysis - Frequently Asked Questions

Antibe Therapeutics' stock was trading at $0.2156 at the beginning of 2025. Since then, ATBPF stock has increased by 0.0% and is now trading at $0.2156.

Antibe Therapeutics Inc. (OTCMKTS:ATBPF) posted its quarterly earnings results on Monday, November, 13th. The company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.02.

Shares of ATBPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/13/2023
Today
10/18/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ATBPF
CIK
N/A
Fax
N/A
Employees
11
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
($0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-56.48%
Return on Assets
-29.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.06
Quick Ratio
10.06

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.58 per share
Price / Book
0.37

Miscellaneous

Outstanding Shares
52,981,000
Free Float
48,238,000
Market Cap
$11.42 million
Optionable
Not Optionable
Beta
0.51

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:ATBPF) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners